Great article by Parsl.co, highlighting the Catch-22 situation experienced by researchers in most nations around the world when they want to study medical marijuana.
However, due to a lack of quality research into medicinal cannabis, there is a real lack of peer-reviewed evidence that supports these claims.
Often this means healthcare professionals are reluctant to prescribe medicinal cannabis to patients who could benefit greatly from the medicine, even in jurisdictions where cannabis is legal, as they don’t have concrete evidence to support their decisions when prescribing the medication.
This not only prevents health care practitioners from helping patients who are desperate to reap in the benefits of the medicine, it is also holding the industry back from growing further and discovering new methods of using the plant to treat various illnesses.
Head over to Smoke.io to read the full article